| Literature DB >> 29228814 |
Alysson Wagner Fernandes Duarte1,2, Juliana Aparecida Dos Santos3, Marina Vitti Vianna3, Juliana Maíra Freitas Vieira3, Vitor Hugo Mallagutti3, Fabio José Inforsato3, Lia Costa Pinto Wentzel3, Luciana Daniela Lario4,5, Andre Rodrigues3, Fernando Carlos Pagnocca3, Adalberto Pessoa Junior5, Lara Durães Sette3.
Abstract
Antarctica is the coldest, windiest, and driest continent on Earth. In this sense, microorganisms that inhabit Antarctica environments have to be adapted to harsh conditions. Fungal strains affiliated with Ascomycota and Basidiomycota phyla have been recovered from terrestrial and marine Antarctic samples. They have been used for the bioprospecting of molecules, such as enzymes. Many reports have shown that these microorganisms produce cold-adapted enzymes at low or mild temperatures, including hydrolases (e.g. α-amylase, cellulase, chitinase, glucosidase, invertase, lipase, pectinase, phytase, protease, subtilase, tannase, and xylanase) and oxidoreductases (laccase and superoxide dismutase). Most of these enzymes are extracellular and their production in the laboratory has been carried out mainly under submerged culture conditions. Several studies showed that the cold-adapted enzymes exhibit a wide range in optimal pH (1.0-9.0) and temperature (10.0-70.0 °C). A myriad of methods have been applied for cold-adapted enzyme purification, resulting in purification factors and yields ranging from 1.70 to 1568.00-fold and 0.60 to 86.20%, respectively. Additionally, some fungal cold-adapted enzymes have been cloned and expressed in host organisms. Considering the enzyme-producing ability of microorganisms and the properties of cold-adapted enzymes, fungi recovered from Antarctic environments could be a prolific genetic resource for biotechnological processes (industrial and environmental) carried out at low or mild temperatures.Keywords: Antarctica; bioprospecting; cold-adapted enzymes; extremophiles; filamentous fungi; mycology; psychrophiles; yeasts
Mesh:
Substances:
Year: 2017 PMID: 29228814 DOI: 10.1080/07388551.2017.1379468
Source DB: PubMed Journal: Crit Rev Biotechnol ISSN: 0738-8551 Impact factor: 8.429